Diabetic Eye Disease

Latest News


CME Content


Scott F. Schwartz, OD, of Detroit, MI

Patients with diabetes may need to add a dry eye workup to their health assessments. Scott Schwartz, OD, from Detroit, MI, discusses his poster, “Does diabetes make a difference in dry eye,” at ARVO 2018 in Honolulu.

It is important for eyecare providers to be familiar with these new drugs and findings. We often see patients with diabetes, metabolic syndrome, and high CV risk, and we are in a position to help counsel our patients about new treatments-and even suggest that appropriate patients have conversations with their primary-care physicians, endocrinologists and cardiologists.

A 30-year-old female with a 16-year history of insulin-dependent diabetes and no other ocular or systemic conditions developed proliferative retinopathy in March 2015. She had not been closely followed for the previous five years.

Diabetic retinopathy (DR) in patients is a common finding in optometric practices. When we grade the level of retinopathy, we often do so with findings of the Early Treatment Diabetic Retinopathy Study (ETDRS)in mind.

A colleague recently told me that eye doctors should “stay within the lines” of traditional eye care because we barely have enough time as it is to do our jobs. My response was that today more than half of our adult patients have either diabetes or prediabetes, so our job now requires we go ”outside the lines” to avoid the leading cause of preventable blindness.

Given this abundance of nonhuman species living on and within our bodies, it is not surprising that there is a link between specific bacteria to systemic and ocular disease-including diabetes and diabetes-related eye disease.